Zevra Therapeutics (ZVRA) Return on Capital Employed [ROCE] (2015 - 2026)
Zevra Therapeutics' Return on Capital Employed [ROCE] was 34.04% in Q2 2026, up 98.20 percentage points from -64.16% a year earlier and up 36.36 percentage points from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Zevra Therapeutics came in at -32.76%, up 28.88 percentage points from FY2024.
- Return on Capital Employed [ROCE] shows a five-year change of +136.09 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -61.63% in FY2024 (+9.11 pp), -70.75% in FY2023 (-32.78 pp), -37.96% in FY2022 (-49.36 pp) and 11.39% in FY2021 (+180.24 pp).
- The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2015.
- Compared with a year earlier, Return on Capital Employed [ROCE] has increased for four straight quarters, with an average year-over-year change of +22.44 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2021 (a gain of 158.72 percentage points); the worst was Q1 2023 (a drop of 55.28 percentage points).
- Per Business Quant data, ZVRA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -2.32% (Q1 2026), -26.43% (Q4 2025) and -36.98% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Zevra Therapeutics | 592.83 Mn | -219.88 Mn | 38.18 Mn | 34.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.04% |
| Mar 31, 2026 | -2.32% |
| Dec 31, 2025 | -26.43% |
| Sep 30, 2025 | -36.98% |
| Jun 30, 2025 | -64.16% |
| Mar 31, 2025 | -48.42% |
| Dec 31, 2024 | -57.70% |
| Sep 30, 2024 | -64.98% |
| Jun 30, 2024 | -63.72% |
| Mar 31, 2024 | -43.41% |
| Dec 31, 2023 | -60.54% |
| Sep 30, 2023 | -43.53% |
| Jun 30, 2023 | -39.89% |
| Mar 31, 2023 | -56.15% |
| Dec 31, 2022 | -40.38% |
| Sep 30, 2022 | -31.81% |
| Jun 30, 2022 | -26.90% |
| Mar 31, 2022 | -0.86% |
| Dec 31, 2021 | 5.91% |
| Sep 30, 2021 | 5.48% |
API Access
Zevra Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();